Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

Journal of Experimental Medicine

Volumn 190, Issue 2, 1999, Pages 169-176

  Kammer, Andreas R ^a   Van Der Burg, Sjoerd H ^b   Grabscheid, Benno ^a   Hunziker, Isabelle P ^a   Kwappenberg, Kitty M C ^b   Reichen, Jürg ^a   Melief, Cornelis J M ^b   Cerny, Andreas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigens, viral; Autoimmunity; Hepatitis C like viruses; Hepatitis, autoimmune; HLA A2 antigen

Indexed keywords

CYTOCHROME P450; EPITOPE; HLA A2 ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CELLULAR IMMUNITY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MOLECULAR MIMICRY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ARYL HYDROCARBON HYDROXYLASES; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; CYTOCHROME P-450 ENZYME SYSTEM; EPITOPES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HLA-A2 ANTIGEN; HUMANS; LIVER; MIXED FUNCTION OXYGENASES; MOLECULAR MIMICRY; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033584232     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.2.169     Document Type: Article

References (48)

1. Franco, A., V. Barnaba, G. Ruberti, R. Benvenuto, C. Balsano, and A. Musca. 1990. Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory cell function of hepatocytes expressing class II major histocompatibility complex molecules. Clin. Immunol. Immunopathol. 54:382-394.
2. Wen, L., M. Peakman, A. Lobo-Yeo, B.M. McFarlane, A.P. Mowat, G. Mieli-Vergani, and D. Vergani. 1990. T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. Lancet. 336:1527-1530.
3. Manns, M.P., E.F. Johnson, K.J. Griffin, E.M. Tan, and K.F. Sullivan. 1989. Major antigen of liver kidney microsomal auto-antibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J. Clin. Invest. 83:1066-1072.
4. Lohr, H., M. Manns, A. Kyriatsoulis, A.W. Lohse, C. Trautwein, K.H. Meyer zum Buschenfelde, and B. Fleischer. 1991. Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin. Exp. Immunol. 84:297-302.
5. + LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology. 24:1416-1421.
6. Lenzi, M., G. Ballardini, M. Fusconi, F. Cassani, L. Selleri, U. Volta, D. Zauli, and F.B. Bianchi. 1990. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet. 335: 258-259.
7. Garson, J.A., M. Lenzi, C. Ring, F. Cassani, G. Ballardini, M. Briggs, R.S. Tedder, and F.B. Bianchi. 1991. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J. Med. Virol. 34:223-226.
8. Koziel, M.J., D. Dudley, J.T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B.D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
9. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, I. Nakamura, Y. Yazaki, and M. Imawari. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 18:1039-1044.
10. Cerny, A., J.G. McHutchison, C. Pasquinelli, M.E. Brown, M.A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F.V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521-530.
11. Battegay, M., J. Fikes, A.M. Di Bisceglie, P.A. Wentworth, A. Sette, E. Celis, W.M. Ching, A. Grakoui, C.M. Rice, K. Kurokohchi, et al. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462-2470.
12. Shirai, M., T. Arichi, M. Nishioka, T. Nomura, K. Ikeda, K. Kawanishi, V.H. Engelhard, S.M. Feinstone, and J.A. Berzofsky. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733-2742.
13. Wentworth, P.A., A. Sette, E. Celis, J. Sidney, S. Southwood, C. Crimi, S. Stitely, E. Keogh, N.C. Wong, B. Livingston, et al. 1996. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int. Immunol. 8:651-659.
14. Ruppert, J., J. Sidney, E. Celis, R.T. Kubo, H.M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:929-937.
15. del Guercio, M.F., J. Sidney, G. Hermanson, C. Perez, H.M. Grey, R.T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685-693.
16. Oldstone, M.B. 1987. Molecular mimicry and autoimmune disease. Cell. 50:819-820.
17. von Herrath, M.G., and M.B. Oldstone. 1996. Virus-induced autoimmune disease. Curr. Opin. Immunol. 8:878-885.
18. Davies, J.M. 1997. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol. Cell. Biol. 75:113-126.
19. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
20. Talbot, P.J., J.S. Paquette, C. Ciurli, J.P. Antel, and F. Ouellet. 1996. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann. Neurol. 39:233-240.
21. van Eden, W., E.J. Hogervorst, E.J. Hensen, R. van der Zee, J.D. van Embden, and I.R. Cohen. 1989. A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr. Top. Microbiol. Immunol. 145:27-43.
22. Malkiel, S., A.P. Kuan, and B. Diamond. 1996. Autoimmunity in heart disease: mechanisms and genetic susceptibility. Mol. Med. Today. 2:336-342.
23. Zhao, Z.S., F. Granucci, L. Yeh, P.A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 279:1344-1347.
24. + cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J. Neuroimmunol. 73:7-14.
25. +/- human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology. 82:89-104.
26. van der Burg, S.H., E. Ras, J.W. Drijfhout, W.E. Benck-huijsen, A.J. Bremers, C.J. Melief, and W.M. Kast. 1995. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum. Immunol. 44:189-198.
27. Parham, P., and F.M. Brodsky. 1981. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3:277-299.
28. van der Burg, S.H., M.J. Visseren, R.M. Brandt, W.M. Kast, and C.J. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308-3314.
29. Koziel, M.J., D. Dudley, N. Afdhal, Q.L. Choo, M. Houghton, R. Ralston, and B.D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
30. Rehermann, B., K.M. Chang, J.G. McHutchison, R. Kokka, M. Houghton, and F.V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432-1440.
31. al-Ramadi, B.K., M.T. Jelonek, L.F. Boyd, D.H. Margulies, and A.L. Bothwell. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:662-673.
32. de Vries, J.E., H. Yssel, and H. Spits. 1989. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes. Immunol. Rev. 109:119-141.
33. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 369:403-407.
34. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:407-410.
35. Sloan-Lancaster, J., and P.M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27.
36. Hollsberg, P., W.E. Weber, F. Dangond, V. Batra, A. Sette, and D.A. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA. 92:4036-4040.
37. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:515-518.
38. + T cells in response to antagonist ligands. J. Exp. Med. 184:149-157.
39. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:148-151.
40. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
41. Mackie, F.D., M. Peakman, M. Yun, R. Sallie, H. Smith, E.T. Davies, G. Mieli-Vergani, and D. Vergani. 1994. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology. 106:1672-1675.
42. Vento, S., F. Cainelli, C. Renzini, and C. Ercole. 1997. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance. Lancet. 350:1298-1299.
43. + T-cell-deficient mice. J. Virol. 68:4700-4704.
44. + cytotoxic T-cell responses during chronic viral infection. J. Virol 68:8056-8063.
45. + T cells. J. Exp. Med. 184:863-871.
46. Zajac, A.J., J.N. Blattman, K. MuraliKrishna, D.J.D. Sourdive, M. Suresh, J.D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
47. Kirby, G.M., G. Batist, L. Alpert, E. Lamoureux, R.G. Cameron, and M.A. Alaoui-Jamali. 1996. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis. Toxicol. Pathol. 24:458-467.
48. Vento, S., L. Guella, and E. Concia. 1995. Discordant manifestations of hepatitis C in monozygotic twins. N. Engl. J. Med. 333:1224-1225.